Mittie Doyle is a Chief Medical Officer who has filed 14 SEC Form 4 insider transactions across 3 companies since 2022. The most recent filing, for AVTX, was dated Jun 1, 2026. Across all open-market trades the lifetime net is −$2.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $705.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.